Scott Myers's Insider Trades & SAST Disclosures
Scott Myers's most recent trade in Zentalis Pharmaceuticals Inc was a trade of 21,000 Common Stock done at an average price of $1.4 . Disclosure was reported to the exchange on April 30, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Scott Myers.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zentalis Pharmaceuticals Inc | Scott D. Myers | Director | Purchase of securities on an exchange or from another person at price $ 1.40 per share. | 30 Apr 2025 | 21,000 | 281,192 | - | 1.4 | 29,373 | Common Stock |
| Zentalis Pharmaceuticals Inc | Myers D. Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2024 | 260,192 | 260,192 | - | 0 | Common Stock | |
| Dynavax Technologies Corp. | Scott D. Myers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Scott D. Myers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 5,357 | 25,446 (0%) | 0% | 0 | Common Stock | |
| California Bancorp | Scott Myers | SEVP, Chief Lending Offier | Sale of securities on an exchange or to another person at price $ 24.68 per share. | 01 Feb 2024 | 2,564 | 20,075 | - | 24.7 | 63,280 | Common Stock |
| Harpoon Therapeutics Inc | D. Myers Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 2,048 | 22,666 (0%) | 0% | 0 | Common Stock | |
| California Bancorp | Scott Myers | SEVP, Chief Lending Offier | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2023 | 2,500 | 22,639 | - | 0 | Common Stock | |
| California Bancorp | Scott Myers | SEVP, Chief Lending Offier | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Aug 2023 | 20,000 | 0 | - | - | Stock Option (right to buy) | |
| California Bancorp | Scott Myers | SEVP, Chief Lending Offier | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Aug 2023 | 8,290 | 0 | - | 0 | Common Stock | |
| California Bancorp | Scott Myers | SEVP, Chief Lending Offier | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Aug 2023 | 5,500 | 0 | - | - | Stock Option (right to buy) | |
| California Bancorp | Scott Myers | SEVP, Chief Lending Offier | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Aug 2023 | 5,500 | 0 | - | - | Stock Option (right to buy) | |
| California Bancorp | Scott Myers | SEVP, Chief Lending Offier | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Aug 2023 | 5,500 | 0 | - | - | Stock Option (right to buy) | |
| California Bancorp | Scott Myers | SEVP, Chief Lending Offier | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Aug 2023 | 5,500 | 0 | - | - | Stock Option (right to buy) | |
| California Bancorp | Scott Myers | SEVP, Chief Lending Offier | Sale of securities on an exchange or to another person at price $ 18.66 per share. | 03 Aug 2023 | 3,254 | 16,133 | - | 18.7 | 60,720 | Common Stock |
| California Bancorp | Scott Myers | SEVP, Chief Lending Offier | Sale of securities on an exchange or to another person at price $ 24.68 per share. | 03 Aug 2023 | 2,564 | 12,879 | - | 24.7 | 63,280 | Common Stock |
| California Bancorp | Scott Myers | SEVP, Chief Lending Offier | Sale of securities on an exchange or to another person at price $ 21.90 per share. | 03 Aug 2023 | 1,298 | 8,290 | - | 21.9 | 28,426 | Common Stock |
| California Bancorp | Scott Myers | SEVP, Chief Lending Offier | Sale of securities on an exchange or to another person at price $ 22.09 per share. | 03 Aug 2023 | 806 | 9,270 | - | 22.1 | 17,805 | Common Stock |
| California Bancorp | Scott Myers | SEVP, Chief Lending Offier | Sale of securities on an exchange or to another person at price $ 21.99 per share. | 03 Aug 2023 | 632 | 9,902 | - | 22.0 | 13,898 | Common Stock |
| California Bancorp | Scott Myers | SEVP, Chief Lending Offier | Sale of securities on an exchange or to another person at price $ 22.99 per share. | 03 Aug 2023 | 413 | 10,315 | - | 23.0 | 9,495 | Common Stock |
| California Bancorp | Scott Myers | SEVP, Chief Lending Offier | Sale of securities on an exchange or to another person at price $ 21.85 per share. | 03 Aug 2023 | 174 | 8,464 | - | 21.9 | 3,802 | Common Stock |
| Harpoon Therapeutics Inc | Scott D. Myers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2023 | 35,634 | 98,215 (0%) | 0% | 0 | Common Stock | |
| Harpoon Therapeutics Inc | Scott D. Myers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 46,000 | 46,000 | - | - | Director Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Scott D. Myers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Scott D. Myers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 5,357 | 20,089 (0%) | 0% | 0 | Common Stock | |
| Viridian Therapeutics Inc | Scott D. Myers | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 25.37 per share. | 12 Apr 2023 | 4,000 | 259,500 (0%) | 0% | 25.4 | 101,479 | Common Stock |
| Harpoon Therapeutics Inc | Scott D. Myers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2023 | 34,925 | 62,581 (0%) | 0% | 0 | Common Stock | |
| Viridian Therapeutics Inc | Scott D. Myers | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 29.15 per share. | 13 Mar 2023 | 5,500 | 255,500 (0%) | 0% | 29.1 | 160,324 | Common Stock |
| California Bancorp | Scott Myers | SEVP, Chief Lending Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 5,500 | 5,500 | - | - | Stock Option (right to buy) | |
| California Bancorp | Scott Myers | SEVP, Chief Lending Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 3,500 | 20,139 | - | 0 | Common Stock | |
| Viridian Therapeutics Inc | Scott D. Myers | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2023 | 1,000,000 | 1,000,000 | - | - | Stock Option (Right to Buy) | |
| Viridian Therapeutics Inc | Scott D. Myers | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2023 | 250,000 | 250,000 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Scott D. Myers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2023 | 87,500 | 87,500 | - | - | Stock Option (Right to Buy) | |
| Harpoon Therapeutics Inc | Scott D. Myers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 20,334 | 20,334 | - | - | Director Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Scott D. Myers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 16,875 | 16,875 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Scott D. Myers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 4,018 | 4,018 | - | - | Restricted Stock Unit | |
| California Bancorp | Scott Myers | SEVP, Chief Lending Offier | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 1,000 | 17,639 | - | 0 | Common Stock | |
| California Bancorp | Scott Myers | SEVP, Chief Lending Offier | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2022 | 5,500 | 5,500 | - | - | Stock Option (right to buy) | |
| California Bancorp | Scott Myers | SEVP, Chief Lending Offier | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2022 | 1,350 | 16,639 | - | 0 | Common Stock | |
| Selecta Biosciences Inc | Scott D. Myers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Harpoon Therapeutics Inc | Scott D. Myers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Oct 2021 | 10,167 | 10,167 | - | - | Director Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Scott D. Myers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Oct 2021 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Dynavax Technologies Corp. | Scott D. Myers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Oct 2021 | 10,714 | 10,714 | - | - | Restricted Stock Unit | |
| Selecta Biosciences Inc | Scott D. Myers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2021 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| California Bancorp | Scott Myers | SEVP, Chief Lending Offier | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2021 | 5,500 | 5,500 | - | - | Stock Option (right to buy) | |
| California Bancorp | Scott Myers | SEVP, Chief Lending Offier | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2021 | 4,850 | 15,289 | - | 0 | Common Stock | |
| Selecta Biosciences Inc | Scott Myers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2020 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Harpoon Therapeutics Inc | Scott Myers | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2020 | 10,167 | 10,167 | - | - | Director Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges